Earnings call: Bristol Myers Squibb raises full-year EPS guidance By Investing.com

Bristol Myers (NYSE: BMY ) Squibb (BMS) has reported a robust second-quarter performance with an 18% year-over-year increase in growth portfolio revenues, or 21% excluding foreign exchange impact. The company has raised its full-year earnin
Read more...